Skip to main content

UBS Group AG

Position in MDGL — Madrigal Pharmaceuticals, Inc.

CIK 1610520 ZURICH, V8

Position in MDGL

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$215,697,109
+$154,043,337 QoQ
Shares Held
401,708
+241.1% QoQ
Ownership
1.74%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#12
of 402 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 87% Shared 0% None 13%

Common Shares in MDGL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,751,271,661 across 562 Biotechnology names. MDGL ranks #8 (2.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
8 MDGL
Madrigal Pharmaceuticals, Inc.
This page
401,708 $215,697,109

All Filings in MDGL

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $215,697,109 401,708
2026-03-31 $61,653,772 117,779
2025-12-31 $59,771,957 102,641
2025-09-30 $99,686,539 217,343
2025-06-30 $153,049,284 505,714
2025-03-31 $106,492,762 321,507
2024-12-31 $100,369,797 325,274
2024-09-30 $38,333,296 180,630
2024-06-30 $48,534,917 173,240
2024-03-31 $33,490,819 125,415
2023-12-31 $20,448,669 88,377
2023-09-30 $8,205,257 56,185
2023-06-30 $5,364,975 23,225
2023-03-31 $7,491,404 30,923
2022-12-31 $28,064,272 96,690
2022-09-30 $1,654,840 25,463
2022-06-30 $1,301,682 18,185
2022-03-31 $2,917,008 29,729
2021-12-31 $1,875,464 22,132
2021-09-30 $1,724,580 21,614
2021-06-30 $592,057 6,078
2021-03-31 $1,943,806 16,618
2020-12-31 $267,475 2,406
2020-09-30 $304,066 2,561
2020-06-30 $281,879 2,489
2020-03-31 $640,093 9,588